These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2991964)

  • 1. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats.
    Yamada K; Tanaka M; Shibata K; Furukawa T
    Psychopharmacology (Berl); 1986; 90(1):9-13. PubMed ID: 2945222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats.
    Dourish CT; Hutson PH
    Neuropharmacology; 1985 Nov; 24(11):1051-5. PubMed ID: 3935946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76.
    Dourish CT; Herbert EN; Iversen SD
    Neuropharmacology; 1989 Dec; 28(12):1423-5. PubMed ID: 2615920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist.
    Dourish CT
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):3-27. PubMed ID: 6304814
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.
    Walters JR; Bunney BS; Roth RH
    Adv Neurol; 1975; 9():273-84. PubMed ID: 167566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between yawning behavior and central serotonergic neuronal system in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):667-72. PubMed ID: 2957600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis.
    Morelli M; Longoni R; Spina L; Di Chiara G
    Psychopharmacology (Berl); 1986; 89(2):259-60. PubMed ID: 3088647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral interactions between naloxone and dopamine agonists.
    Harris RA; Snell D; Loh HH; Way EL
    Eur J Pharmacol; 1977 Jun; 43(3):243-6. PubMed ID: 872878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats.
    Matsumoto S; Yamada K; Nagashima M; Matsuo N; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):815-8. PubMed ID: 2525786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
    Porreca F; Cowan A; Tallarida RJ
    Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Facilitation of a stereotyped motor behavior (climbing behavior) by previous stimulation of dopaminergic receptors: hyposensitivity of autoreceptors?].
    Costentin J; Marçais H; Protais P; Baudry M; Martres MP; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(2):143-6. PubMed ID: 402241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR; Argiolas A; Gessa GL
    Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)-3-PPP and (-)-3-PPP by recording of yawning behaviour in rats.
    Ståhle L; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):307-10. PubMed ID: 6714314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of apomorphine, piribedil and haloperidol on adrenal ornithine decarboxylase activity of the rat.
    Almazan G; Ramirez-Gonzalez MD; Sourkes TL
    Neuropharmacology; 1982 Jul; 21(7):631-7. PubMed ID: 6889689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):22-32. PubMed ID: 4026462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.